Claims
- 1. Purified, isolated cammunocin, substantially free of the microorganism Streptomyces species Y-84,36210, having the UV spectrum in methanol shown in FIG. 3, with bands at about 234 nm, 280 nm and 340 nm and the IR spectrum in KBr as shown in FIG. 4, with bands at about 3400 cm.sup.-1, 1680 cm.sup.-1, 1559 cm.sup.-1, 1250 cm.sup.-1, and 600 cm.sup.-1 and requiring the presence of calcium to exhibit an antibacterial effect against gram-positive bacteria.
- 2. Cammunocin as claimed in claim 1, obtained by cultivating Streptomyces species Y-84,36210 and subsequently isolating and purifying cammunocin.
- 3. A pharmaceutical composition which comprises cammunocin as claimed in claim 2, together with one or both of a pharmaceutically acceptable auxiliary and vehicle.
- 4. A pharmaceutical composition according to claim 3 having antibacterial activity against gram-positive bacteria in the presence of calcium.
- 5. A pharmaceutical composition according to claim 3 having immunosuppressant activity.
- 6. A pharmaceutical composition according to claim 3 having antibiotic activity.
Priority Claims (1)
Number |
Date |
Country |
Kind |
3803383 |
Feb 1988 |
DEX |
|
Parent Case Info
This application is a continuation of application Ser. No. 07/305,270 filed Feb. 2, 1989, now abandoned.
US Referenced Citations (7)
Non-Patent Literature Citations (3)
Entry |
Eliopoulus et al. 1986. Antimicrobiol Agents and Chemotherapy, Oct. pp. 532-535. |
CRC Handbook of Antibiotic Compounds, vol. IV, Part 1, pp. 313-321, Janos Berdy (author), CRC Press, Boca Raton, Florida (1980). |
Debono et al., J. Antibiotics 40:761-777 (1987). |
Continuations (1)
|
Number |
Date |
Country |
Parent |
305270 |
Feb 1989 |
|